Cytek Biosciences
CTKB
CTKB
103 hedge funds and large institutions have $654M invested in Cytek Biosciences in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 24 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.15% more ownership
Funds ownership: 45.35% → 47.5% (+2.2%)
27% less capital invested
Capital invested by funds: $899M → $654M (-$245M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
103
Holding in Top 10
2
Calls
$1.97M
Puts
$65K
Top Buyers
| 1 | +$10.7M | |
| 2 | +$7.16M | |
| 3 | +$4.87M | |
| 4 |
BlackRock
New York
|
+$4.59M |
| 5 |
Goldman Sachs
New York
|
+$2.69M |
Top Sellers
| 1 | -$8.17M | |
| 2 | -$2.82M | |
| 3 | -$2.8M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.75M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$1.09M |